Shalby per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹3.50₹3.23₹0.18₹7.78₹6.31
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹3.50₹3.23₹0.18₹7.77₹6.27
₹93.49₹93.49₹92.31₹93.13₹86.45
₹109.40₹106.16₹101.12₹86.93₹75.01
—−₹0.00−₹0.40₹1.82₹6.32
−₹13.86−₹13.86−₹7.05−₹2.56₹4.59
—₹0.00₹1.21₹1.21₹1.01
10.810.810.710.710.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHALBY₹112.10

Shalby Limited

· Pharma & Health
₹ CrorePeersGKSLGPTHEALTHINDRAMEDCOARTEMISMEDLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹1,205 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS6.317.780.183.233.50
Diluted EPS6.277.770.183.233.50
Book Value per Share86.4593.1392.3193.4993.49
Revenue per Share75.0186.93101.12106.16109.40
Cash Flow per Share6.321.82-0.40-0.00—
Free Cash Flow per Share4.59-2.56-7.05-13.86-13.86
Dividends per Share1.011.211.210.00—
Shares Outstanding (cr)10.710.710.710.810.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.